PANBELA THERAPEUTICS INC (PBLA)       1.43  -0.18 (-11.18%)

1.43  -0.18 (-11.18%)

US69833W1071 - Common Stock - After market: 1.5 +0.07 (+4.9%)

PANBELA THERAPEUTICS INC1.43

NASDAQ:PBLA (1/27/2023, 7:27:00 PM)-0.18 (-11.18%)

After market: 1.5 +0.07 (+4.9%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-10 2022-11-10/amc Earnings (Next) 03-22 2023-03-22
Ins Owners 85.76% Inst Owners N/A
Market Cap 1.13M Shares 792.80K
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 80
IPO 07-29 2014-07-29

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PBLA Daily chart

Company Profile

Panbela Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Waconia, Minnesota and currently employs 4 full-time employees. The company went IPO on 2014-07-29. Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm is focused on developing disruptive therapeutics for the treatment of patients with cancer. Its primary focus is on the treatment of patients with pancreatic cancer. Its lead product candidate, SBP-101, is a polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma, ovarian cancer and other tumors. The firm is conducting Phase Ia/Ib study of the safety, tolerability and pharmacokinetics of SBP-101 when administered in combination with gemcitabine and nab-paclitaxel.

Company Info

PANBELA THERAPEUTICS INC

712 Vista Blvd # 305

Waconia MINNESOTA 55387

P: 19524791196.0

CEO: Jennifer K. Simpson

Employees: 4

Website: https://panbela.com/about-us/company-overview/

PBLA News

News Image9 hours ago - ChartmillWhich stocks are moving after the closing bell on Friday?

Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.

News Imagea day ago - ChartmillTop movers in Thursday's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.

News Image2 days ago - ChartmillWhat's going on in today's session

Let's have a look at the top gainers and losers in the middle of the day of today's session.

News Image2 days ago - ChartmillThese stocks are gapping in today's session

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

News Image2 days ago - Seeking AlphaPanbela stock nosedives ~40% on pricing stock and warrants offering (NASDAQ:PBLA)

Panbela Therapeutics (PBLA) said Thursday it priced public offering of 6,675,000 shares of its common stock and warrants to purchase up to 13,350,000 shares.

News Image2 days ago - Panbela Therapeutics, Inc.Panbela Announces Pricing of Approximately $15 Million Public Offering

PBLA Twits

Here you can normally see the latest stock twits on PBLA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example